Larissa Nekhlyudov is a professor in the Department of Medicine at Harvard Medical School and is a practicing internist at the Brigham & Women's Hospital...
In CheckMate 9ER study among patients with previously untreated advanced renal-cell carcinoma (RCC), nivolumab plus cabozantinib had significant benefits over sunitinib in terms of...
Larissa Nekhlyudov is a professor in the Department of Medicine at Harvard Medical School and is a practicing internist at the Brigham & Women's Hospital...
In CheckMate 9ER study among patients with previously untreated advanced renal-cell carcinoma (RCC), nivolumab plus cabozantinib had significant benefits over sunitinib in terms of...